| Bacillus Calmette-Guérin (BCG) therapy for bladder cancer: an update S Guallar-Garrido, E Julián ImmunoTargets and Therapy, 1-11, 2020 | 197 | 2020 |
| Swarming behavior and in vivo monitoring of enzymatic nanomotors within the bladder AC Hortelao, C Simó, M Guix, S Guallar-Garrido, E Julián, D Vilela, L Rejc, ... Science Robotics 6 (52), eabd2823, 2021 | 188 | 2021 |
| Urease-powered nanobots for radionuclide bladder cancer therapy C Simó, M Serra-Casablancas, AC Hortelao, V Di Carlo, ... Nature Nanotechnology 19 (4), 554-564, 2024 | 40 | 2024 |
| Mycobacteria emulsified in olive oil-in-water trigger a robust immune response in bladder cancer treatment E Noguera-Ortega, N Blanco-Cabra, RM Rabanal, A Sánchez-Chardi, ... Scientific Reports 6 (1), 27232, 2016 | 24 | 2016 |
| Mycobacteria-based vaccines as immunotherapy for non-urological cancers E Noguera-Ortega, S Guallar-Garrido, E Julián cancers 12 (7), 1802, 2020 | 19 | 2020 |
| Mycolicibacterium brumae is a safe and non-toxic immunomodulatory agent for cancer treatment M Bach-Griera, V Campo-Pérez, S Barbosa, S Traserra, S Guallar-Garrido, ... Vaccines 8 (2), 198, 2020 | 16 | 2020 |
| Each Mycobacterium Requires a Specific Culture Medium Composition for Triggering an Optimized Immunomodulatory and Antitumoral Effect S Guallar-Garrido, V Campo-Pérez, A Sánchez-Chardi, M Luquin, ... Microorganisms 8 (5), 734, 2020 | 16 | 2020 |
| BCG Substrains change their outermost surface as a function of growth media S Guallar-Garrido, F Almiñana-Rapún, V Campo-Pérez, E Torrents, ... Vaccines 10 (1), 40, 2021 | 9 | 2021 |
| Analysis of the lipid composition of mycobacteria by thin layer chromatography S Guallar-Garrido, M Luquin, E Julián JoVE (Journal of Visualized Experiments), e62368, 2021 | 8 | 2021 |
| Mycobacterial surface characters remodeled by growth conditions drive different tumor-infiltrating cells and systemic IFN-γ/IL-17 release in bladder cancer treatment S Guallar-Garrido, V Campo-Pérez, M Pérez-Trujillo, C Cabrera, ... OncoImmunology 11 (1), 2051845, 2022 | 4 | 2022 |
| The High Plasticity of Nonpathogenic Mycobacterium brumae Induces Rapid Changes in Its Lipid Profile during Pellicle Maturation: The Potential of This Bacterium … V Campo-Pérez, S Guallar-Garrido, M Luquin, A Sánchez-Chardi, ... International Journal of Molecular Sciences 23 (21), 13609, 2022 | 2 | 2022 |
| Remodeling the bladder tumor immune microenvironment by mycobacterial species with changes in their cell envelope composition J Senserrich, S Guallar-Garrido, E Gomez-Mora, V Urrea, B Clotet, ... Frontiers in immunology 13, 993401, 2022 | 2 | 2022 |
| Exploring host–pathogen interactions in the Dictyostelium discoideum–Mycobacterium marinum infection model of tuberculosis S Guallar-Garrido, T Soldati Disease Models & Mechanisms 17 (7), dmm050698, 2024 | 1 | 2024 |
| Radionuclide therapy based on accumulated urease-powered nanobots in the bladder tumor of an orthotopic murine model C Simó, M Serra-Casablancas, A Hortelao, V Di Carlo, S Guallar-Garrido, ... | | 2023 |
| Mycobacteria factors responsible for modifying the antitumour activity in bladder cancer S Guallar Garrido | | 2021 |
